Penserra Capital Management LLC Kodiak Sciences Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$80.85 - $128.49 $95,403 - $151,618	-1,180 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$81.97 - $106.94 $1,229 - $1,604	15 Added 1.29%	1,180 $113,000
Q2 2021 Aug 12, 2021	BUY	$77.2 - $126.54 $1,544 - $2,530	20 Added 1.75%	1,165 $108,000
Q1 2021 May 13, 2021	SELL	$110.45 - $164.47 $2,209 - $3,289	-20 Reduced 1.72%	1,145 $129,000
Q4 2020 Feb 12, 2021	BUY	$60.78 - $154.03 $47,590 - $120,605	783 Added 204.97%	1,165 $171,000
Q3 2020 Nov 13, 2020	BUY	$45.05 - $59.27 $17,209 - $22,641	382 New	382 $22,000

109

40.9M

28.4K

21.2K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $151M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.